These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7543459)

  • 21. Characterization of a family of monoclonal antibodies which bind Schistosoma japonicum egg antigens and express an interstrain cross-reactive idiotype.
    Olds GR; Kresina TF
    Parasite Immunol; 1990 Mar; 12(2):199-211. PubMed ID: 1690872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum.
    McManus DP; Liu S; Song G; Xu Y; Wong JM
    Int J Parasitol; 1998 Nov; 28(11):1739-42. PubMed ID: 9846611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes.
    Waine GJ; Yang W; Scott JC; McManus DP; Kalinna BH
    Vaccine; 1997 Jun; 15(8):846-8. PubMed ID: 9234530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The possibility of GST antigen from Chinese strain of Schistosoma japonicum for immunodiagnosis of schistosomiasis.
    Liu SX; Song GC; Ding LY; Lin ZC; Cai ZH
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):70-3. PubMed ID: 8362311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult schistosome cDNA libraries as a source of antigens for the study of experimental and human schistosomiasis.
    Knight M; Simpson AJ; Bickle Q; Hagan P; Moloney A; Wilkins A; Smithers SR
    Mol Biochem Parasitol; 1986 Feb; 18(2):235-53. PubMed ID: 2938004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening and cloning of genes encoding Schistosoma japonicum antigens related to the serum antibodies in Mirotus fortis].
    Yan YT; Liu SX; Song GC; Xu YX; He YK
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(3):153-6. PubMed ID: 12571940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of Schistosoma japonicum Sjp40, a potential antigen candidate for the early diagnosis of schistosomiasis.
    Zhou XH; Wu JY; Huang XQ; Kunnon SP; Zhu XQ; Chen XG
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):337-45. PubMed ID: 20638601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Passively transferable protection against Schistosoma japonicum induced in the mouse by multiple vaccination with attenuated larvae: the development of immunity, antibody isotype responses and antigen recognition.
    Dunne DW; Jones FM; Cook L; Moloney NA
    Parasite Immunol; 1994 Dec; 16(12):655-68. PubMed ID: 7708432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody Signatures Reflect Different Disease Pathologies in Patients With Schistosomiasis Due to Schistosoma japonicum.
    Driguez P; Li Y; Gaze S; Pearson MS; Nakajima R; Trieu A; Doolan DL; Felgner PL; Hou X; Cardoso FC; Jasinskas A; Gobert GN; Loukas A; McManus DP
    J Infect Dis; 2016 Jan; 213(1):122-30. PubMed ID: 26150545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection and immunological study on two tetraspanin-derived vaccine candidates against schistosomiasis japonicum.
    Chen L; Chen Y; Zhang D; Hou M; Yang B; Zhang F; Zhang W; Luo X; Ji M; Wu G
    Parasite Immunol; 2016 Oct; 38(10):589-98. PubMed ID: 27189226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of vaccines for schistosomiasis.
    McManus DP; Loukas A
    Clin Microbiol Rev; 2008 Jan; 21(1):225-42. PubMed ID: 18202444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.
    Jiz M; Friedman JF; Leenstra T; Jarilla B; Pablo A; Langdon G; Pond-Tor S; Wu HW; Manalo D; Olveda R; Acosta L; Kurtis JD
    Infect Immun; 2009 May; 77(5):2051-8. PubMed ID: 19273558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and immunogenicity of a recombinant pseudorabies virus expressing Sj26GST and SjFABP from Schistosoma japonicum.
    Wei F; Zhai Y; Jin H; Shang L; Men J; Lin J; Fu Z; Shi Y; Zhu XQ; Liu Q; Gao H
    Vaccine; 2010 Jul; 28(32):5161-6. PubMed ID: 20561603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoblot analysis of Schistosoma japonicum egg antigens with sera from patients with acute and chronic schistosomiasis japonica.
    Kirinoki M; Hu M; Yokoi H; Chigusa Y; Matsuda H
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):702-7. PubMed ID: 15115074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The soluble worm antigens-specific antibodies used as biomarkers of Schistosoma japonicum in a low prevalence and intensity endemic area of Hubei, China.
    Zhao J; Chen X; Long X; Rafaels N; Campbell M; Liang H; Zhang B; Barnes KC; Hamilton RG; Chen Q
    Acta Trop; 2019 Jul; 195():28-34. PubMed ID: 30986379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
    James SL; Pearce EJ; Sher A
    J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine CD8(+)T cell cytotoxicity against schistosomula induced by inoculation of schistosomal 22.6/26GST coupled Sepharose 4B beads.
    Zhou Y; Zhang H; Sun XJ; Zheng D; Liang YJ; Luo J; Wang Y; Zhang ZS
    Vaccine; 2012 Mar; 30(14):2440-7. PubMed ID: 22326902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy evaluation induced by recombinant protein LHD-Sj23-GST of Schistosoma japonicum emulsified with three different adjuvants.
    Zhu Z; Fu Z; Zhang M; Han Y; Hong Y; Li D; Zhao Z; Shi Y; Li X; Lin J
    Parasite Immunol; 2012 Jun; 34(6):341-4. PubMed ID: 22329493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody isotype responses to paramyosin, a vaccine candidate for schistosomiasis, and their correlations with resistance and fibrosis in patients infected with Schistosoma japonicum in Leyte, The Philippines.
    Nara T; Iizumi K; Ohmae H; Sy OS; Tsubota S; Inaba Y; Tsubouchi A; Tanabe M; Kojima S; Aoki T
    Am J Trop Med Hyg; 2007 Feb; 76(2):384-91. PubMed ID: 17297052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status and future prospects for a vaccine against schistosomiasis.
    Lebens M; Sun JB; Czerkinsky C; Holmgren J
    Expert Rev Vaccines; 2004 Jun; 3(3):315-28. PubMed ID: 15176948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.